These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 27174314)

  • 21. Pharmacokinetics of tazarotene and acitretin in psoriasis.
    Heath MS; Sahni DR; Curry ZA; Feldman SR
    Expert Opin Drug Metab Toxicol; 2018 Sep; 14(9):919-927. PubMed ID: 30134735
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Novel microemulsion-based gel formulation of tazarotene for therapy of acne.
    Patel MR; Patel RB; Parikh JR; Patel BG
    Pharm Dev Technol; 2016 Dec; 21(8):921-932. PubMed ID: 26334480
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Dual roles of TPGS based microemulsion for tacrolimus: Enhancing the percutaneous delivery and anti-psoriatic efficacy.
    Wan T; Pan J; Long Y; Yu K; Wang Y; Pan W; Ruan W; Qin M; Wu C; Xu Y
    Int J Pharm; 2017 Aug; 528(1-2):511-523. PubMed ID: 28629978
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Efficacy of pulsed dye laser plus topical tazarotene versus topical tazarotene alone in psoriatic nail disease: a single-blind, intrapatient left-to-right controlled study.
    Huang YC; Chou CL; Chiang YY
    Lasers Surg Med; 2013 Feb; 45(2):102-7. PubMed ID: 23423871
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparison of tazarotene 0.1% gel plus petrolatum once daily versus calcipotriol 0.005% ointment twice daily in the treatment of plaque psoriasis.
    Tzung TY; Wu JC; Hsu NJ; Chen YH; Ger LP
    Acta Derm Venereol; 2005; 85(3):236-9. PubMed ID: 16040409
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of nanoparticles with hydrotropic nicotinamide on tacrolimus: permeability through psoriatic skin and antipsoriatic and antiproliferative activities.
    Wan T; Pan W; Long Y; Yu K; Liu S; Ruan W; Pan J; Qin M; Wu C; Xu Y
    Int J Nanomedicine; 2017; 12():1485-1497. PubMed ID: 28260894
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Obtaining the optimal treatment outcome with tazarotene.
    McClelland PB
    Dermatol Nurs; 1998 Oct; 10(5):343-8. PubMed ID: 9873273
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Periungual pyogenic granulomas due to topical tazarotene for nail psoriasis.
    Piraccini BM; Venturi M; Patrizi A
    G Ital Dermatol Venereol; 2014 Jun; 149(3):363-6. PubMed ID: 24819765
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Tazarotene-loaded
    Erol İ; Üstündağ Okur N; Orak D; Sipahi H; Aydın A; Özer Ö
    Pharm Dev Technol; 2020 Oct; 25(8):909-918. PubMed ID: 32364036
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Topical retinoids in inflammatory acne: a retrospective, investigator-blinded, vehicle-controlled, photographic assessment.
    Leyden JJ; Shalita A; Thiboutot D; Washenik K; Webster G
    Clin Ther; 2005 Feb; 27(2):216-24. PubMed ID: 15811485
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Tazarotene: therapeutic strategies in the treatment of psoriasis, acne and photoaging.
    Roeder A; Schaller M; Schäfer-Korting M; Korting HC
    Skin Pharmacol Physiol; 2004; 17(3):111-8. PubMed ID: 15087589
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Tolerability of Topical Retinoids: Are There Clinically Meaningful Differences Among Topical Retinoids?
    Culp L; Moradi Tuchayi S; Alinia H; Feldman SR
    J Cutan Med Surg; 2015; 19(6):530-8. PubMed ID: 26088502
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clinical efficacy and safety of tazarotene: optimizing clinical results.
    Lebwohl M
    Cutis; 1998 Feb; 61(2 Suppl):27-9. PubMed ID: 9787989
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Solid lipid nanoparticles and nanostructured lipid carrier-based nanotherapeutics in treatment of psoriasis: a comparative study.
    Arora R; Katiyar SS; Kushwah V; Jain S
    Expert Opin Drug Deliv; 2017 Feb; 14(2):165-177. PubMed ID: 27882780
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Lower irritation microemulsion-based rotigotine gel: formulation optimization and in vitro and in vivo studies.
    Wang Z; Mu HJ; Zhang XM; Ma PK; Lian SN; Zhang FP; Chu SY; Zhang WW; Wang AP; Wang WY; Sun KX
    Int J Nanomedicine; 2015; 10():633-44. PubMed ID: 25609965
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Delivery of adapalene using a novel topical gel based on tea tree oil nano-emulsion: Permeation, antibacterial and safety assessments.
    Najafi-Taher R; Ghaemi B; Amani A
    Eur J Pharm Sci; 2018 Jul; 120():142-151. PubMed ID: 29684425
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Tazarotene induces epidermal cell differentiation in the mouse tail test used as an animal model for psoriasis.
    Sebök B; Bonnekoh B; Kerényi M; Gollnick H
    Skin Pharmacol Appl Skin Physiol; 2000; 13(5):285-91. PubMed ID: 10940819
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Molecular mechanisms of tazarotene action in psoriasis.
    Duvic M; Nagpal S; Asano AT; Chandraratna RA
    J Am Acad Dermatol; 1997 Aug; 37(2 Pt 3):S18-24. PubMed ID: 9270552
    [TBL] [Abstract][Full Text] [Related]  

  • 39. In vitro compatibility of tazarotene with other topical treatments of psoriasis.
    Hecker D; Worsley J; Yueh G; Lebwohl M
    J Am Acad Dermatol; 2000 Jun; 42(6):1008-11. PubMed ID: 10827404
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Treatment Modalities of Psoriasis: A Focus on Requisite for Topical Nanocarrier.
    Ramanunny AK; Wadhwa S; Thakur D; Singh SK; Kumar R
    Endocr Metab Immune Disord Drug Targets; 2021; 21(3):418-433. PubMed ID: 32496998
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.